|
TMEM39A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.042900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.004600E-03 |
| Normal-vs-Stage2 |
4.651800E-02 |
| Normal-vs-Stage3 |
1.994260E-02 |
| Normal-vs-Stage4 |
2.215600E-03 |
| Stage1-vs-Stage2 |
8.070800E-01 |
| Stage1-vs-Stage3 |
9.823400E-01 |
| Stage1-vs-Stage4 |
1.537820E-01 |
| Stage2-vs-Stage3 |
8.439600E-01 |
| Stage2-vs-Stage4 |
3.743800E-01 |
| Stage3-vs-Stage4 |
2.002400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.964600E-04 |
| Normal-vs-AfricanAmerican |
7.131600E-01 |
| Normal-vs-Asian |
8.637400E-03 |
| Caucasian-vs-AfricanAmerican |
1.090160E-02 |
| Caucasian-vs-Asian |
2.635000E-01 |
| AfricanAmerican-vs-Asian |
2.126100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.213800E-02 |
| Normal-vs-Female |
1.83122999999341E-05 |
| Male-vs-Female |
5.975600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.444600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.620200E-04 |
| Normal-vs-Age(61-80Yrs) |
5.662400E-03 |
| Normal-vs-Age(81-100Yrs) |
7.844200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.193200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.305400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.586600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.768200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.412300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.151620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.373820E-02 |
| Normal-vs-Grade 2 |
1.578340E-03 |
| Normal-vs-Grade 3 |
2.623800E-02 |
| Normal-vs-Grade 4 |
5.641800E-03 |
| Grade 1-vs-Grade 2 |
4.051400E-01 |
| Grade 1-vs-Grade 3 |
2.251200E-01 |
| Grade 1-vs-Grade 4 |
7.822400E-01 |
| Grade 2-vs-Grade 3 |
2.760000E-01 |
| Grade 2-vs-Grade 4 |
4.287400E-01 |
| Grade 3-vs-Grade 4 |
1.563200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.615200E-04 |
| Normal-vs-ccB subtype |
5.075700E-03 |
| ccA subtype-vs-ccB subtype |
4.130200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.774400E-04 |
| Normal-vs-N1 |
2.334200E-02 |
| N0-vs-N1 |
1.648960E-01 |
|
|
